Cargando…

The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients

AIM: The main complication of Endoscopic retrograde cholangiopancreatography (ERCP) is post-ERCP pancreatitis (PEP). BACKGROUND: Based on demographic characteristics and underlying issues and ERCP indication, patients are categorized as high risk or low risk. There have been no studies on the synerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghajanpoor Pasha, Morteza, Eslami, Pegah, Dooghaie Moghadam, Arash, Moazzami, Bobak, shojaee, Sajad, Almasi, Faezeh, Tavakolikia, Narjes, Norouzinia, Mohsen, Radinnia, Ebrahim, Sadeghi, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881403/
https://www.ncbi.nlm.nih.gov/pubmed/33585008
_version_ 1783650870482698240
author Aghajanpoor Pasha, Morteza
Eslami, Pegah
Dooghaie Moghadam, Arash
Moazzami, Bobak
shojaee, Sajad
Almasi, Faezeh
Tavakolikia, Narjes
Norouzinia, Mohsen
Radinnia, Ebrahim
Sadeghi, Amir
author_facet Aghajanpoor Pasha, Morteza
Eslami, Pegah
Dooghaie Moghadam, Arash
Moazzami, Bobak
shojaee, Sajad
Almasi, Faezeh
Tavakolikia, Narjes
Norouzinia, Mohsen
Radinnia, Ebrahim
Sadeghi, Amir
author_sort Aghajanpoor Pasha, Morteza
collection PubMed
description AIM: The main complication of Endoscopic retrograde cholangiopancreatography (ERCP) is post-ERCP pancreatitis (PEP). BACKGROUND: Based on demographic characteristics and underlying issues and ERCP indication, patients are categorized as high risk or low risk. There have been no studies on the synergistic effects of NSAIDS and hydration therapy, separately sorted by the risk assessment of PEP in different groups of patients. METHODS: This study included 281 eligible participants after exclusion. According to demographic characteristics and co-morbidities, the patients were divided to high risk and low risk. The high-risk group was divided randomly into two subgroups and both of them received NSAIDs (100 mg rectal Diclofenac). One group received standard hydration (1.5mg/kg/hr), another the other received aggressive hydration (3mg/kg/h). The low-risk group received standard hydration. One of its subgroups received NSAIDs, while others did not. The efficacy of these preventions was compared across 4 subgroups. RESULTS: The mean age was 59.85±17.17. Eight hours after ERCP, the amylase and lipase were significantly higher in the high-risk group with standard hydration (P=0.00). Amylase, lipase 8 hours, between two low risk subgroups, NSAIDs had no significant effect (P=0.38, P=0.95, respectively). After adjustment based on cannulation, manipulation and duration of time, the results had no change (P=0.64, P=0.19, P=0.61). CONCLUSION: The aggressive hydration could significantly decrease the risk of PEP. However, the low-risk group was exposed to the lowest risk of PEP. NSAIDs could not help to decrease the rate PEP in the low-risk groups alone. Overall, it seems hydration and NSAIDs therapy had synergistic outcome in high-risk patients.
format Online
Article
Text
id pubmed-7881403
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-78814032021-02-13 The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients Aghajanpoor Pasha, Morteza Eslami, Pegah Dooghaie Moghadam, Arash Moazzami, Bobak shojaee, Sajad Almasi, Faezeh Tavakolikia, Narjes Norouzinia, Mohsen Radinnia, Ebrahim Sadeghi, Amir Gastroenterol Hepatol Bed Bench Original Article AIM: The main complication of Endoscopic retrograde cholangiopancreatography (ERCP) is post-ERCP pancreatitis (PEP). BACKGROUND: Based on demographic characteristics and underlying issues and ERCP indication, patients are categorized as high risk or low risk. There have been no studies on the synergistic effects of NSAIDS and hydration therapy, separately sorted by the risk assessment of PEP in different groups of patients. METHODS: This study included 281 eligible participants after exclusion. According to demographic characteristics and co-morbidities, the patients were divided to high risk and low risk. The high-risk group was divided randomly into two subgroups and both of them received NSAIDs (100 mg rectal Diclofenac). One group received standard hydration (1.5mg/kg/hr), another the other received aggressive hydration (3mg/kg/h). The low-risk group received standard hydration. One of its subgroups received NSAIDs, while others did not. The efficacy of these preventions was compared across 4 subgroups. RESULTS: The mean age was 59.85±17.17. Eight hours after ERCP, the amylase and lipase were significantly higher in the high-risk group with standard hydration (P=0.00). Amylase, lipase 8 hours, between two low risk subgroups, NSAIDs had no significant effect (P=0.38, P=0.95, respectively). After adjustment based on cannulation, manipulation and duration of time, the results had no change (P=0.64, P=0.19, P=0.61). CONCLUSION: The aggressive hydration could significantly decrease the risk of PEP. However, the low-risk group was exposed to the lowest risk of PEP. NSAIDs could not help to decrease the rate PEP in the low-risk groups alone. Overall, it seems hydration and NSAIDs therapy had synergistic outcome in high-risk patients. Shaheed Beheshti University of Medical Sciences 2020 /pmc/articles/PMC7881403/ /pubmed/33585008 Text en ©2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Aghajanpoor Pasha, Morteza
Eslami, Pegah
Dooghaie Moghadam, Arash
Moazzami, Bobak
shojaee, Sajad
Almasi, Faezeh
Tavakolikia, Narjes
Norouzinia, Mohsen
Radinnia, Ebrahim
Sadeghi, Amir
The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
title The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
title_full The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
title_fullStr The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
title_full_unstemmed The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
title_short The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
title_sort synergistic impact of nsaids and aggressive hydration therapy on the rate of post-ercp pancreatitis in high -risk and low -risk patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881403/
https://www.ncbi.nlm.nih.gov/pubmed/33585008
work_keys_str_mv AT aghajanpoorpashamorteza thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT eslamipegah thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT dooghaiemoghadamarash thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT moazzamibobak thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT shojaeesajad thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT almasifaezeh thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT tavakolikianarjes thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT norouziniamohsen thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT radinniaebrahim thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT sadeghiamir thesynergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT aghajanpoorpashamorteza synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT eslamipegah synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT dooghaiemoghadamarash synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT moazzamibobak synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT shojaeesajad synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT almasifaezeh synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT tavakolikianarjes synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT norouziniamohsen synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT radinniaebrahim synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients
AT sadeghiamir synergisticimpactofnsaidsandaggressivehydrationtherapyontherateofpostercppancreatitisinhighriskandlowriskpatients